Symmetric dimethylarginine is a stronger predictor of mortality risk than asymmetric dimethylarginine among older people with kidney disease.
Patel, Liyona
Symmetric dimethylarginine is a stronger predictor of mortality risk than asymmetric dimethylarginine among older people with kidney disease. [electronic resource] - Annals of clinical biochemistry 05 2019 - 367-374 p. digital
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
1758-1001
10.1177/0004563218822655 doi
Aged
Aged, 80 and over
Arginine--analogs & derivatives
Biomarkers--blood
Cohort Studies
Female
Glomerular Filtration Rate
Humans
Male
Renal Insufficiency, Chronic--blood
Risk Assessment
Symmetric dimethylarginine is a stronger predictor of mortality risk than asymmetric dimethylarginine among older people with kidney disease. [electronic resource] - Annals of clinical biochemistry 05 2019 - 367-374 p. digital
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
1758-1001
10.1177/0004563218822655 doi
Aged
Aged, 80 and over
Arginine--analogs & derivatives
Biomarkers--blood
Cohort Studies
Female
Glomerular Filtration Rate
Humans
Male
Renal Insufficiency, Chronic--blood
Risk Assessment